Innovative pipeline development strategy
Differentiated R&D for Fast New Drug Success and Profitability
- core pipeline
- Pipeline
- Indication
- Route of
Administration
-
Discovery
Preclinical
Phase Ⅰ
Phase Ⅲ
Launch
-
Oral
Phase 2a study (us) Clinical Study Reports received in Apr 2024
-
Oral
Completed phase 1 study (US) in Jun 2022
-
Oral
Phase 2b first patient enrolled in Feb 2023
-
Injection
Preclinical study in progress
-
Injection
Preclinical study in progress
- emerging pipeline
- Pipeline
- Indication
- Route of
Administration
-
Discovery
Preclinical
Phase Ⅰ
Phase Ⅲ
Launch
-
Oral
Phase 2 study IND approval(US) in Jun 2023 / IND approval(Europe) in Dec 2023
-
Oral
Completed phase 1 study (US) in Jun 2022
-
Oral
Finalized phase 2 CSR in Jan 2022
-
Oral
Preparing for preclinical studies
-
Oral
Preparing for phase 2b/3 study
-
Injection
Preclinical study in progress
-
Injection
-
Injection
-
Injection
-
Injection
-
Injection